Bosentan. Role in the treatment of pulmonary arterial hypertension

被引：0
|
作者：
Carlos Grignola, Juan [1 ]
Gomez Sanchez, Miguel Angel [2 ]
机构：
[1] Univ Republica, Fac Med, Dept Fisiopatol, Montevideo, Uruguay
[2] Hosp Univ Doce Octubre, Serv Cardiol, Unidad Insuficiencia Cardiaca & Hipertens Pulmona, Ctra Andalucia Km 5-400, Madrid 28041, Spain
来源：
INSUFICIENCIA CARDIACA | 2009年 / 4卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 22
页数：12
相关论文
共 50 条
  • [1] Bosentan for the treatment of pulmonary arterial hypertension
    Kenyon, KW
    Nappi, JM
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (7-8) : 1055 - 1062
  • [2] Sitaxsentan therapy in pulmonary arterial hypertension results in significantly fewer liver function abnormalities than bosentan.
    Coyne, T
    Dixon, R
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S168 - S168
  • [3] Mildly symptomatic pulmonary arterial Hypertension Treatment with Bosentan?
    Halank, M.
    [J]. PNEUMOLOGE, 2009, 6 (01): : 35 - +
  • [4] Bosentan, hope or reality for the treatment of pulmonary arterial hypertension
    Rubio, JLC
    Centeno, NO
    Martinez, MNB
    Torres-Pujol, JMDH
    [J]. MEDICINA CLINICA, 2004, 123 (04): : 158 - 159
  • [5] Bosentan: A novel agent for the treatment of pulmonary arterial hypertension
    O'Callaghan, D
    Gaine, SP
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (01) : 69 - 73
  • [6] Bosentan.: Treatment of pulmonary hypertension, treatment of heart failure, antihypertensive, endothelin ETA/ETB antagonist.
    Mealy, NE
    Bayès, M
    del Fresno, M
    [J]. DRUGS OF THE FUTURE, 2001, 26 (12) : 1149 - 1154
  • [7] Bosentan for the treatment of pulmonary arterial hypertension associated to scleroderma
    Hachulla, E.
    Launay, D.
    Humbert, M.
    [J]. REVUE DE MEDECINE INTERNE, 2007, 28 : S221 - S226
  • [8] Response of patients with pulmonary arterial hypertension that do not qualify for treatment with bosentan to treatment with bosentan
    Bshouty, Z
    [J]. CHEST, 2005, 128 (04) : 367S - 367S
  • [9] Palosuran Treatment Effective as Bosentan in the Treatment Model of Pulmonary Arterial Hypertension
    Pehlivan, Yavuz
    Dokuyucu, Recep
    Demir, Tuncer
    Kaplan, Davut Sinan
    Koc, Ibrahim
    Orkmez, Mustafa
    Turkbeyler, Ibrahim Halil
    Ceribasi, Ali Osman
    Tutar, Ediz
    Taysi, Seyithan
    Kisacik, Bunyamin
    Onat, Ahmet Mesut
    [J]. INFLAMMATION, 2014, 37 (04) : 1280 - 1288
  • [10] Palosuran Treatment Effective as Bosentan in the Treatment Model of Pulmonary Arterial Hypertension
    Yavuz Pehlivan
    Recep Dokuyucu
    Tuncer Demir
    Davut Sinan Kaplan
    Ibrahim Koc
    Mustafa Orkmez
    Ibrahim Halil Turkbeyler
    Ali Osman Ceribasi
    Ediz Tutar
    Seyithan Taysi
    Bunyamin Kisacik
    Ahmet Mesut Onat
    [J]. Inflammation, 2014, 37 : 1280 - 1288
12345